These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31604427)

  • 21. Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
    Wang M; Roussos P; McKenzie A; Zhou X; Kajiwara Y; Brennand KJ; De Luca GC; Crary JF; Casaccia P; Buxbaum JD; Ehrlich M; Gandy S; Goate A; Katsel P; Schadt E; Haroutunian V; Zhang B
    Genome Med; 2016 Nov; 8(1):104. PubMed ID: 27799057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein Clustering and Interactome Analysis in Parkinson and Alzheimer's Diseases.
    Rezaei-Tavirani M; Zamanian-Azodi M; Rajabi S; Masoudi-Nejad A; Rostami-Nejad M; Rahmatirad S
    Arch Iran Med; 2016 Feb; 19(2):101-9. PubMed ID: 26838080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. microRNAs and Neurodegenerative Diseases.
    Qiu L; Tan EK; Zeng L
    Adv Exp Med Biol; 2015; 888():85-105. PubMed ID: 26663180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptomic profiling of differentially expressed genes and related pathways in different brain regions in Parkinson's disease.
    Jia E; Pan M; Liu Z; Zhou Y; Zhao X; Dong J; Bai Y; Ge Q
    Neurosci Lett; 2020 Jul; 732():135074. PubMed ID: 32446776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the Common Molecular Basis in Alzheimer's and Parkinson's Diseases.
    Rana P; Franco EF; Rao Y; Syed K; Barh D; Azevedo V; Ramos RTJ; Ghosh P
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deciphering complex mechanisms in neurodegenerative diseases: the advent of systems biology.
    Noorbakhsh F; Overall CM; Power C
    Trends Neurosci; 2009 Feb; 32(2):88-100. PubMed ID: 19135729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
    Ross CA; Pickart CM
    Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies.
    López González I; Garcia-Esparcia P; Llorens F; Ferrer I
    Int J Mol Sci; 2016 Feb; 17(2):206. PubMed ID: 26861289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational prediction of changes in brain metabolic fluxes during Parkinson's disease from mRNA expression.
    Supandi F; van Beek JHGM
    PLoS One; 2018; 13(9):e0203687. PubMed ID: 30208076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders.
    Yang Y; Jiang S; Yan J; Li Y; Xin Z; Lin Y; Qu Y
    Cytokine Growth Factor Rev; 2015 Feb; 26(1):47-57. PubMed ID: 25280871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ghrelin and Neurodegenerative Disorders-a Review.
    Shi L; Du X; Jiang H; Xie J
    Mol Neurobiol; 2017 Mar; 54(2):1144-1155. PubMed ID: 26809582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of intrinsically unstructured proteins in neurodegenerative diseases.
    Raychaudhuri S; Dey S; Bhattacharyya NP; Mukhopadhyay D
    PLoS One; 2009; 4(5):e5566. PubMed ID: 19440375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene networks in neurodegenerative disorders.
    Recabarren D; Alarcón M
    Life Sci; 2017 Aug; 183():83-97. PubMed ID: 28623007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detecting and analyzing differentially activated pathways in brain regions of Alzheimer's disease patients.
    Liu ZP; Wang Y; Zhang XS; Xia W; Chen L
    Mol Biosyst; 2011 May; 7(5):1441-52. PubMed ID: 21336338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PGC-1α sparks the fire of neuroprotection against neurodegenerative disorders.
    Lv J; Jiang S; Yang Z; Hu W; Wang Z; Li T; Yang Y
    Ageing Res Rev; 2018 Jul; 44():8-21. PubMed ID: 29580918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards a Pathway Inventory of the Human Brain for Modeling Disease Mechanisms Underlying Neurodegeneration.
    Iyappan A; Gündel M; Shahid M; Wang J; Li H; Mevissen HT; Müller B; Fluck J; Jirsa V; Domide L; Younesi E; Hofmann-Apitius M
    J Alzheimers Dis; 2016 Apr; 52(4):1343-60. PubMed ID: 27079715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomarkers in Neurodegenerative Diseases.
    Jeromin A; Bowser R
    Adv Neurobiol; 2017; 15():491-528. PubMed ID: 28674995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases.
    Egensperger R; Kösel S; Schnopp NM; Mehraein P; Graeber MB
    Neuropathol Appl Neurobiol; 1997 Aug; 23(4):315-21. PubMed ID: 9292870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The regulatory role of non-coding RNAs and their interactions with phytochemicals in neurodegenerative diseases: a systematic review.
    Fakhri S; Darvish E; Narimani F; Moradi SZ; Abbaszadeh F; Khan H
    Brief Funct Genomics; 2023 Apr; 22(2):143-160. PubMed ID: 36722043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitric oxide in neurodegenerative diseases.
    Zhao B
    Front Biosci; 2005 Jan; 10():454-61. PubMed ID: 15574382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.